Literature DB >> 18459463

Analysis of the composition of plasma lipoproteins in patients with extensive coronary heart disease using 1H NMR spectroscopy.

Athanasios Papathanasiou1, Christina Kostara, Manh-Thong Cung, Konstantin Seferiadis, Moses Elisaf, Eleni Bairaktari, Ioannis A Goudevenos.   

Abstract

INTRODUCTION: Alterations in the lipid composition and overall structure of plasma lipoproteins have been correlated with pathological situations such as dyslipidaemia, coronary heart disease (CHD), hypertension, and renal disease. In the present study 1H NMR spectroscopy was used to analyse the lipid composition of HDL and nonHDL lipoproteins in patients with triple vessel CHD and in patients with normal coronary arteries.
METHODS: Serum samples were collected from 50 patients with triple vessel CHD and 41 patients with normal coronary vessels, both documented angiographically. The classical risk factors for CHD were recorded and each patient's standard lipid profile was determined. HDL and nonHDL lipoprotein particles were separated by precipitation with Dextran Sulphate/MgCl2. HDL and nonHDL lipid fractions were extracted with chloroform:methanol (1:2, v/v). 1H NMR spectra were recorded on a Bruker DRX-600 spectrometer.
RESULTS: In the HDL fraction of patients with triple vessel disease the percentage of triglycerides was significantly higher than in those with normal coronary arteries, whereas the percentages of cholesterol esters, phosphatidylcholine and sphingomyelin, as well as polyunsaturated fatty acids, such as linoleic, arachidonic, and eicosapentaenoic, were significantly lower. In the nonHDL fraction significantly higher levels of triglycerides and lower levels of polyunsaturated fatty acids were observed.
CONCLUSIONS: Patients with established CHD show significant alterations in the composition of plasma lipoproteins compared to those with normal coronary arteries. Further study of plasma lipoprotein composition might be able to identify components as indexes for the existence of CHD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18459463

Source DB:  PubMed          Journal:  Hellenic J Cardiol        ISSN: 1109-9666


  8 in total

Review 1.  Unraveling the complexities of the HDL lipidome.

Authors:  Anatol Kontush; Marie Lhomme; M John Chapman
Journal:  J Lipid Res       Date:  2013-03-30       Impact factor: 5.922

2.  HDL (High-Density Lipoprotein) Subclasses, Lipid Content, and Function Trajectories Across the Menopause Transition: SWAN-HDL Study.

Authors:  Samar R El Khoudary ( سمر رياض الخضري ); Xirun Chen (陈曦润); Alexis Nasr ( ألكسس نصر ); Jeff Billheimer; Maria Mori Brooks; Dan McConnell; Trevor J Orchard; Sybil L Crawford; Karen A Matthews; Daniel J Rader
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-12-03       Impact factor: 8.311

3.  The pleiotropic vasoprotective functions of high density lipoproteins (HDL).

Authors:  Guilaine Boyce; Emily Button; Sonja Soo; Cheryl Wellington
Journal:  J Biomed Res       Date:  2017-05-26

Review 4.  Unravelling HDL-Looking beyond the Cholesterol Surface to the Quality Within.

Authors:  Sarina Kajani; Sean Curley; Fiona C McGillicuddy
Journal:  Int J Mol Sci       Date:  2018-07-06       Impact factor: 5.923

5.  Distinct Fatty Acid Compositions of HDL Phospholipids Are Characteristic of Metabolic Syndrome and Premature Coronary Heart Disease-Family Study.

Authors:  Timo Paavola; Ulrich Bergmann; Sanna Kuusisto; Sakari Kakko; Markku J Savolainen; Tuire Salonurmi
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923

Review 6.  Sphingomyelin in high-density lipoproteins: structural role and biological function.

Authors:  Roberto Martínez-Beamonte; Jose M Lou-Bonafonte; María V Martínez-Gracia; Jesús Osada
Journal:  Int J Mol Sci       Date:  2013-04-09       Impact factor: 5.923

Review 7.  Dysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and Lipidomics.

Authors:  Juan Salazar; Luis Carlos Olivar; Eduardo Ramos; Mervin Chávez-Castillo; Joselyn Rojas; Valmore Bermúdez
Journal:  Cholesterol       Date:  2015-11-08

8.  Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer.

Authors:  Vidar G Flote; Riyas Vettukattil; Tone F Bathen; Thore Egeland; Anne McTiernan; Hanne Frydenberg; Anders Husøy; Sissi E Finstad; Jon Lømo; Øystein Garred; Ellen Schlichting; Erik A Wist; Inger Thune
Journal:  Lipids Health Dis       Date:  2016-03-12       Impact factor: 3.876

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.